Kenneth L. Berger

NeoStem Oncology LLC is focused on the production and supply of clinically relevant embryonic stem cell derived human cell populations. Founded in 2005, the mission of NeoStem Oncology is to catalyze the efficient development of human therapies based on human embryonic stem cells. The key to this goal is the production and supply of clinically relevant human cell populations using a scalable, efficient and highly reproducible process. They generate human embryonic stem cell (hESC) lines, expand them to clinically and commercially useful numbers, and differentiate them at extremely high purity using fully-defined, proprietary media and GMP processes that are FDA compliant from day one. And they do this at a fraction of the cost of conventional cell manufacturing. As a result, the company can economically supply large quantities of high purity cells for its own clinical development pipeline in specific application areas. It can also supply high purity, fully characterized, clinically relevant human cell populations to companies or other institutions for development of therapies, efficacy screening or creation of toxicity profiles for candidate drugs, or experimental research. NeoStem Oncology LLC is a privately held Delaware Corporation with headquarters and research facilities in Irvine, CA.

cGMP Validation LLC Provides validation and compliance services. The firm offers equipment, laboratory instruments, processes, auditing, risk assessments, regulatory consulting, educational training and computer validation. It serves in the area of medical device, diagnostics, animal health-compliance, biological and finished pharmaceutical facilities industries. The company was founded by Jesse Gillikin in 1997 and is headquartered in Huntersville, NC.

Synbiotics LLC develops, manufactures and markets veterinary diagnostics and services for veterinary practices, livestock and poultry producers, reference laboratories and animal breeders world-wide. The company was founded in 1982 and is headquartered in Florham Park, NJ.

Irvine Pharmaceutical Services, Inc. provides scientific solutions to the pharmaceutical, biotechnology, and medical device industries. Its services include analytical chemistry and development, parental manufacturing, biopharmaceutical and formulation development, drug delivery technologies, microbiology, and structural chemistry. The company was founded by Assad J. Kazeminy in 1988 and is headquartered in Irvine, CA.